版本:
中国

Daiichi Sankyo Co Ltd (4568.T)

4568.T ( 东京证券交易所 )

4,323JPY
15 Aug 2018
涨跌 (%)

¥-64 (-1.46%)
收盘
¥4,387
开盘
¥4,386
当日最高
¥4,393
当日最低
¥4,309
成交量
956,100
平均成交量
1,958,826
52 周最高
¥4,820
52 周最低
¥2,284

Chart for

概况

DAIICHI SANKYO COMPANY, LIMITED是一家主要从事药品生产和销售业务的日本控股公司。该公司于日本、美国、欧洲、中国及巴西市场从事药物研发、制造及销售,以及提供药物生产中间体及基本原料。截至2014年3月31日,该公司拥有100家子公司和4家联营公司。

概况

Beta: 0.82
市值(百万): ¥3,110,433.00
已发行股本(百万): 709.01
股息: 35.00
股息收益率 (%): 1.60

财务指标

  4568.T Industry Sector
P/E (TTM): 52.52 28.54 30.58
EPS (TTM): 83.53 -- --
ROI: 3.41 13.15 12.84
ROE: 4.59 15.15 15.02

Nikkei rises in volatile trade helped by China stock gains

TOKYO, June 20 Japan's Nikkei share average rose in volatile trade on Wednesday, helped by late short-covering following an earlier selloff and a broader recovery in regional sentiment as Chinese shares recovered from a rout in the previous session. 全文
06/20 15:03

Nikkei flat in choppy trade as trade war woes pressures; Kikkoman soars

TOKYO, June 20 Japan's Nikkei share average was flat in choppy trade on Wednesday morning as firms that rely on China demand tumbled on trade war worries, with machine tool makers and shippers posting multi-month lows, which offset gains in defensive stocks. 全文
06/20 11:05

日本股市:受特朗普宣布退出伊核协议影响收跌;丰田大涨3.8%

路透东京5月9日 - 日本股市周三收跌,美国总统特朗普宣布退出伊朗核协议之后,全球弥漫紧张氛围。但丰田股价上涨,此前公布业绩并宣布股票回购。 全文
05/09 14:56

Nikkei drops after Trump quits Iran nuclear deal; Toyota shines after earnings

TOKYO, May 9 Japanese stocks fell on Wednesday as global tensions flared after President Donald Trump pulled the United States out of an international nuclear deal with Iran, but Toyota rose after releasing earnings and announcing a share buyback. 全文
05/09 14:38

日本股市:日经指数下跌,此前美国总统特朗普宣布退出伊核协议

特朗普宣布美国退出与伊朗签订的国际核协议,令中东地区爆发冲突的风险升高,欧洲盟友对此深感不安,全球石油供应也笼罩不确定性。 全文
05/09 11:27

Nikkei drops after Trump quits Iran nuclear deal; Toyota's results eyed

TOKYO, May 9 Japanese stocks slipped on Wednesday morning as investors were cautious after U.S. President Donald Trump pulled the United States out of an international nuclear deal with Iran. 全文
05/09 10:36

BRIEF-Thermo Fisher Scientific Signs New Agreements To Expand Oncomine Dx Target Test

* THERMO FISHER SCIENTIFIC SIGNS NEW AGREEMENTS TO EXPAND ONCOMINE DX TARGET TEST 全文
05/01 19:09

BRIEF-Vaxart Announces $5 Mln Inavir Revenue Milestone

* VAXART - NOTIFIED BY DAIICHI SANKYO CO THAT SALES OF INAVIR EXCEEDED ¥20 BILLION IN FISCAL YEAR 2017, TRIGGERING A $5 MILLION MILESTONE PAYMENT TO CO 全文
04/20 20:06

BRIEF-‍Daiichi Sankyo And Darwinhealth Enter Exclusive Research Collaboration For Novel Cancer Target Initiative​

* ‍DAIICHI SANKYO AND DARWINHEALTH ENTER EXCLUSIVE RESEARCH COLLABORATION FOR NOVEL CANCER TARGET INITIATIVE​ 全文
04/04 20:11

BRIEF-Daiichi Sankyo Initiates Phase 2 Study Of DS-8201

* DAIICHI SANKYO INITIATES PHASE 2 STUDY OF DS-8201 IN PATIENTS WITH HER2-EXPRESSING ADVANCED COLORECTAL CANCER Source text for Eikon: Further company coverage: 全文
03/07 21:15

收益 vs. 预测